Synbio Technologies
Changing the world, one sequence at a time.
Changing the world, one sequence at a time.
Synbio Technologies is a biotechnology startup with a mission to revolutionize scientific discoveries through DNA solutions. Established in 2013, the company offers a comprehensive suite of synthetic biology services and products, including DNA sequencing, synthesis, and engineering capabilities for diverse applications in fields such as diagnostic probes, precision medicine, protein production, and vaccine development. Their expertise spans oligo synthesis, gene synthesis, subcloning, PCR cloning, and bioinformatics analysis, powered by proprietary algorithms for antibody discovery. With a focus on Biotechnology, Health Care, and Pharmaceutical industries, Synbio Technologies aims to be a trusted partner for researchers worldwide.
There is no investment information
No recent news or press coverage available for Synbio Technologies.
We care about your data, and we'd love to use cookies make your experience better.